Erica Rogers

Medicines360 is a nonprofit global women’s health pharmaceutical company with a mission to remove cost as a barrier to health by developing and providing affordable Women’s Health products. Medicines360 is committed to working with healthcare providers, advocacy groups and patients to deliver innovative and meaningful treatments that help women around the world have greater access to the medicines they need. Please see our community guidelines: http://www.medicines360.org/community-guidelines/

Medicines360 is a nonprofit global women’s health pharmaceutical company with a mission to remove cost as a barrier to health by developing and providing affordable Women’s Health products. Medicines360 is committed to working with healthcare providers, advocacy groups and patients to deliver innovative and meaningful treatments that help women around the world have greater access to the medicines they need. Please see our community guidelines: http://www.medicines360.org/community-guidelines/

Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have over $200 million in assets under management.

Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. The company plans to revolutionize the field of cataract surgery by offering the Synchrony® dual optic accommodating IOL. This long-awaited, 3-dimensional device represents a major breakthrough in ophthalmic technology—an IOL that is designed to allow patients to have a continuous range of focus without the use of spectacles or the optical disadvantages of monovision or multifocal implants.